Fenofibrate use had a more pronounced impact on the risk of proliferative diabetic retinopathy, with a 24% decrease in progression (PDR; HR 0.76, 95% CI 0.64-0.90) but did not significantly affect ...

The results of 12-week study have shown that the coadministration of ezetimibe and fenofibrate improved LDL, HDL, and non-HDL cholesterol levels and reduced triglycerides and CRP levels in a ...

Fenofibrate, a lipid-modifying agent that acts as a PPARα agonist, may prevent adipocyte hypertrophy and insulin resistance by increasing intracellular lipolysis from adipose tissue.

The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was a randomized, double-blind, placebo-controlled trial conducted in Australia, New Zealand, and Finland that was ...

We hypothesized that dietary administration of the peroxisomal proliferator-activated receptor α agonist, fenofibrate, to young adult male rats would prevent the fractionated whole-brain irradiation ...

Fenofibrate is primarily used to help reduce elevated levels of triglycerides, or fat, in the blood. But the researchers wanted to know if the drug, when combined with statin treatment, could also ...

Fenofibrate-treated rats also showed decreased concentrations of FFA and CH with concomitant decrease of catecholamine-induced lipolysis in adipocytes, but also hyperinsulinemia and the highest ...

Fenofibrate is a widely available, low-cost generic drug previously approved by the United States Food and Drug Administration and many other regulatory agencies to reduce the amount of fatty ...

Thus, fenofibrate can both prevent primary infection and reduce secondary infection rates. This was confirmed by reduced viral N-gene RNA levels with fenofibrate, in a dose-dependent manner.

Fenofibrate was associated with a reduction in heart failure hospitalizations and cardiovascular-related mortality compared with placebo in patients with type 2 diabetes who received simvastatin ...

JERUSALEM: A widely used anti-cholesterol drug, fenofibrate, can "downgrade" the danger-level of coronavirus to that of a common cold, a Hebrew Univer ...